Energy Fuels' Uranium Revenues Surge 112%, But REE Timeline Confirms Delay

What happened

Energy Fuels reported Q1 2026 revenues of $35.8 million, up 112% year-over-year, driven entirely by uranium sales of $35.7 million. The company delivered 510,000 lbs at a weighted average price of $70.04/lb, with a favorable spot mix lifting realized prices. However, the accompanying 10-Q confirmed that commercial heavy rare earth production has been pushed to 2027, and Phase 2 scale-up is targeted for mid-2029. The Phase 1 circuit still forces switching between uranium and monazite processing, limiting flexibility until 2027 modifications. While the uranium ramp is on track, the REE narrative remains a longer-term story, not a near-term earnings driver.

Implication

The REE timeline delay pushes meaningful earnings contribution from dysprosium/terbium to 2027 at earliest, making the investment thesis dependent on sustained uranium execution and ASM closing. Without a binding offtake or faster REE scale-up, the stock risks re-rating toward a uranium-only valuation.

Thesis delta

The uranium ramp is tracking within guidance, confirming cash generation potential, but the REE timeline slippage (Phase 1 to 2027, Phase 2 to mid-2029) is a material delay that shifts the payoff horizon further out. The crowded 'ex-China rare earths' narrative now faces proof points that are 1-2 years away, increasing the wait risk.